8-isoprostane
metabolite8-isoprostane is a stable F2-isoprostane generated by oxidative modification of arachidonic acid in inflamed plaque and dysfunctional endothelium.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleMarker of lipid peroxidation in atherosclerotic plaque and vascular inflammation.
Also acts inLipid entry/oxidation, Endothelial activation/erosion
Druggability
Not assessed (no mapped human gene target).
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I41
C — confounder / Type-II66
A — assay feasibility42
E — evidence strength25
T1DI (composite)4
Specificity differential (R−C)-24.5
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum, plasma or urine
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
LC-MS/MS (targeted metabolomics) or enzymatic colorimetric where available
Reagent / substrate
Stable-isotope-labeled internal standard (MS); or enzyme-coupled Trinder reagent
Platform
LC-MS/MS; some automated chemistry
Turnaround · availability
Send-out / research · Specialized / research
Literature evidence(1)
- Prediction of myocardial infarction, stroke and cardiovascular mortality with urinary biomarkers of oxidative stress: Results from a large cohort study.International journal of cardiology · 2018 · PMID 30100224 · doi